Method for sterilizing recombinant human serum albumin pharmaceutical preparation
AssigneeThe Green Cross Corporation
InventorsTomoshi Ohya, Toyoo Ohda, Shinobu Kuwae, Kenji Tomomitsu, Kaoru Kobayashi, Takao Ohmura
Life of this patent
Estimating the term…
Abstract
A recombinant human serum albumin (rHSA) pharmaceutical preparation is sterilized by subjecting a pharmaceutical preparation of rHSA obtained by gene manipulation techniques packed in a container in an administration unit to heat treatment at 50.degree. to 80.degree. C. for 30 minutes or more. By the disclosed method, rHSA having high safety can be provided since microorganisms contaminated in rHSA pharmaceutical preparations die as a result of the sterilization method of the present invention.
Claims6
A method for preparing a sterilized recombinant human serum albumin pharmaceutical preparation, comprising subjecting a pharmaceutical preparation of recombinant human serum albumin, which is packed in a container in an administration unit, to heat treatment at 50.degree. to 80.degree. C. for 30 minutes to 2 hours.
Dependencies are inferred from the claim text.